Smoking Clinical Trial
Official title:
Development of a Combined Screening and Intervention Program for Emergency Department Patients Who Both Drink and Smoke
Smoking and drinking are two of the three leading causes of preventable deaths in the United
States today. Using both alcohol and tobacco significantly multiplies the risk of disease and
death from myocardial infarction, COPD, and multiple cancers. Combined use of these
substances is extremely common; people who drink are three times more likely than the general
population to smoke, and tobacco dependent individuals are four times more likely than the
general population to be alcohol-dependent.
Research has shown that there is a high prevalence of unmet substance abuse treatment need
among adult Emergency Department (ED) patients. The current project aims to conduct a pilot
feasibility study with 50 adult ED patients to develop a brief counseling intervention that
is feasible and acceptable to patients who are both smokers and at-risk drinkers to help them
reduce these behaviors.
The overarching aim of this line of research is to find the best treatment for ED patients
who are combo smokers and at-risk drinkers. The study will focus on the development of an
intervention that will be tested in a future larger scale randomized clinical trial.
Smoking and drinking are the most common addictions in this country and frequently co-occur.
Among persons who smoke and drink, there appears to be a robust dose-response relationship,
with heavier drinking associated with heavier smoking and vice versa. Additionally, smokers
who are more alcohol dependent often report that smoking is a common way to cope with the
urge to drink.
Research has shown that there is a high prevalence of unmet substance abuse treatment need
among adult Emergency Department (ED) patients. As many as 46% of ED patients have recently
consumed alcohol and a significant number of the 31.6 million ED injury related visits are
alcohol related. The prevalence rate of tobacco use among ED patients is reportedly as high
as 40% and contributes to significant morbidity and mortality.
For many the ED is the only place they can access medical care. Although most
medically-underserved individuals never seek out specialized treatment for smoking or
drinking, each year over 120 million people visit an ED. Since an ED visit may be a patient's
only point of contact with the health care system, it represents an important opportunity not
only to treat their emergent needs, but to screen and provide this vulnerable population with
appropriate alcohol and tobacco use interventions.
The intervention, built upon the Brief Negotiated Interview (BNI) model, aims to help
patients reduce harmful drinking and smoking and will be initiated during an ED visit
followed by 3 follow up COMBINE counseling telephone sessions post ED visit.
The specific aims of the proposed project are to:
Aim 1: To develop an effective brief intervention for smoker- drinkers that is feasible and
acceptable for patients treated in the emergency department
Aim 2: To identify barriers to treatment engagement and factors that facilitate successful
engagement in alcohol and smoking cessation treatment
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03999411 -
Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients
|
Phase 4 | |
Completed |
NCT03931772 -
Online Automated Self-Hypnosis Program
|
N/A | |
Completed |
NCT02649556 -
A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2
|
N/A | |
Completed |
NCT03901066 -
Smoking Dependence and Periodontitis
|
||
Recruiting |
NCT05846841 -
Personalized Tobacco Treatment in Primary Care (MOTIVATE)
|
N/A | |
Completed |
NCT03170752 -
Implementing and Testing a Cardiovascular Assessment Screening Program (CASP)
|
N/A | |
Completed |
NCT03305978 -
Pulmonary Nodule Detection: Comparison of an Ultra Low Dose vs Standard Scan.
|
N/A | |
Completed |
NCT00000437 -
Tobacco Dependence in Alcoholism Treatment (Nicotine Patch/Naltrexone)
|
Phase 4 | |
Completed |
NCT06105424 -
BRP1602: Evaluation of Technical and Logistical Feasibility to Measure Lung Permeability
|
N/A | |
Active, not recruiting |
NCT02752022 -
Monitoring the Transition From Smoking to E-cigarettes
|
||
Completed |
NCT02912000 -
TEACH: Technology Evaluation to Address Child Health
|
N/A | |
Completed |
NCT04340830 -
The Effect of Smoking on Dimensional Changes of Free Gingival Graft Around Dental Implants
|
N/A | |
Completed |
NCT02901171 -
The Contribution of a Smartphone Application to Acceptance and Commitment Therapy Group Treatment for Smoking Cessation
|
N/A | |
Completed |
NCT03206619 -
A Health Recommeder System to Tailor Message Preferences in a Smoking Cessation Programme
|
||
Completed |
NCT02949648 -
Electronic Cigarette Use and Quitting in Youth
|
N/A | |
Completed |
NCT02945371 -
Tailored Inhibitory Control Training to Reverse EA-linked Deficits in Mid-life
|
N/A | |
Completed |
NCT02246114 -
Self-Monitoring of Carbon Monoxide to Enhance Reproductive Outcomes in Women
|
N/A | |
Completed |
NCT02008292 -
Acetylcholine, Tobacco Smoking, Genes and Nicotinic Receptors
|
N/A | |
Completed |
NCT01898507 -
Nicotine Metabolism and Low Nicotine Cigarettes
|
N/A | |
Completed |
NCT01954407 -
Young Adults' Responses to Anti-smoking Messages
|
N/A |